Evidence map›Paper›PMID 38902719›Full record

ArticleVirology journal2024

Molecular surveillance for dengue serotypes among the population living in Moyen-Ogooué province, Gabon; evidence of the presence of dengue serotype 1.

Rodrigue Bikangui, Soulemane Parkouda, Ayong More, Marien Veraldy Magossou Mbadinga, Ismael Piérrick Mikelet Boussoukou, Georgelin Nguema Ondo, Anne Marie Mouina Nkoma, Rafiou Adamou, Yabo Josiane Honkpehedji, Elie Gide Rossatanga and 6 more

Abstract read
In one paragraph

Article in Virology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rodrigue BikanguiCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon. bikrod16@gmail.com.
Soulemane ParkoudaCentre Hospitalier Régional George RAWIRI, Lambaréné, Gabon.
Ayong MoreCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Marien Veraldy Magossou MbadingaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ismael Piérrick Mikelet BoussoukouCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Georgelin Nguema OndoCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Anne Marie Mouina NkomaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Rafiou AdamouCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Yabo Josiane HonkpehedjiCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Elie Gide RossatangaCentre Hospitalier Régional George RAWIRI, Lambaréné, Gabon.
Yuri UshijimaDepartment of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Haruka AbeDepartment of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Bertrand LellCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Jean Claude Dejon-AgobéCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Jiro YasudaDepartment of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Ayola Akim AdegnikaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Funding

OCEAC MTN project funded by KFW BMZ - Nr 2015.69.227+BMZ - Nr 2016.68.797
6 · The paper itself

Abstract

backgroundDespite dengue virus (DENV) outbreak in Gabon a decade ago, less is known on the potential circulation of DENV serotypes in the country. Previous studies conducted in some areas of the country, are limited to hospital-based surveys which reported the presence of some cases of serotype 2 and 3 seven years ago and more recently the serotype 1. As further investigation, we extend the survey to the community of Moyen Ogooué region with the aim to assess the presence of the dengue virus serotypes, additionally to characterize chikungunya (CHIKV) infection and describe the symptomatology associated with infections.

methodA cross-sectional survey was conducted from April 2020 to March 2021. The study included participants of both sexes and any age one year and above, with fever or history of fever in the past seven days until blood collection. Eligible volunteers were clinically examined, and blood sample was collected for the detection of DENV and CHIKV using RT-qPCR. Positive samples were selected for the target sequencing.

resultsA total of 579 volunteers were included. Their mean age (SD) was 20 (20) years with 55% of them being female. Four cases of DENV infection were diagnosed giving a prevalence of 0.7% (95%CI: 0.2-1.8) in our cohort while no case of CHIKV was detected. The common symptoms and signs presented by the DENV cases included fatigue, arthralgia myalgia, cough, and loss of appetite. DENV-1was the only virus detected by RT-qPCR.

conclusionOur results confirm the presence of active dengue infection in the region, particularly DENV-1, and could suggest the decline of DENV-2 and DENV-3. Continuous surveillance remains paramount to comprehensively describe the extent of dengue serotypes distribution in the Moyen-Ogooué region of Gabon.

Indexed as

DengueDengue VirusSerogroupAdolescentAdultAgedChikungunya FeverChikungunya virusChildChild, PreschoolCross-Sectional StudiesFemaleGabonHumansInfantMaleCirculationDengueGabonMoyen OgoouéSerotypesSymptoms

Identifiers

PMID38902719
PMCPMC11191199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.